EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma

Lei Min, Yujing Weng iD, Yuan Li, Die Liu, Zhiheng Huang

Head & Neck · 2024

DOI: 10.1002/hed.27865 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Head & Neck, 2024. Verfasst von Lei Min und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Neck Dissection, Thyroid Neoplasms, Thyroid Cancer, Papillary, Thyroidectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The American Thyroid Association guidelines primarily recommend central neck dissection for papillary thyroid carcinoma with advanced primary tumors or clinically positive neck nodes. However, the appropriate extent of dissection remains unclear. We aimed to compare the rate of locoregional recurrence between unilateral and bilateral central neck dissection in invasive papillary thyroid carcinoma.

Methods

Among 330 consecutive patients who underwent total thyroidectomy with central neck dissection for advanced papillary thyroid carcinoma, 212 underwent unilateral central neck dissection (UCND group) while 118 underwent bilateral central neck dissection (BCND group). We performed 1:1 propensity score matching, resulting in 99 matched pairs. Surgical outcomes and safety were compared between the two groups. Additionally, the impact of surgery on locoregional recurrence was compared using survival analysis.

Results

During a follow‐up of 47.8 ± 20.4 months, 29 (8.8%) patients experienced locoregional recurrence within the entire study cohort. Following propensity score matching, no significant difference in recurrence‐free survival was observed between the two groups (log‐rank p = 0.516). Multivariate analysis revealed that only T4 staging was an independent risk factor for locoregional recurrence ( p = 0.006). The mean number of total and metastatic central lymph nodes retrieved were significantly greater in BCND group (14.1 vs. 9.3, p < 0.001 and 6.8 vs. 4.6, p = 0.005, respectively). There was no significant difference in postoperative stimulated thyroglobulin levels between the two groups (0.79 ng/mL vs. 1.44 ng/mL, p = 0.389).

Conclusion

The present study demonstrates no prognostic benefit in conducting bilateral central neck dissection. Unilateral central neck dissection may be the preferred choice for clinically invasive papillary thyroid carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neck DissectionThyroid NeoplasmsThyroid Cancer, PapillaryThyroidectomyPropensity ScoreNeoplasm Recurrence, LocalNeoplasm InvasivenessHumansFemaleMaleMiddle AgedAdultRetrospective StudiesNeoplasm StagingAgedSurvival AnalysisDisease-Free Survival

Stichwörter der Autor:innen

locoregional recurrencelymph node metastasisneck dissectionthyroid carcinomathyroid surgery

Autor:innen und Institutionen

  • Department of Thyroid Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Department of Ultrasound, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Yujing Weng

Zitieren

APA

Min, L., Weng, Y., Li, Y., Liu, D., & Huang, Z. (2024). Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma. Head & Neck. https://doi.org/10.1002/hed.27865

Vancouver

Min L, Weng Y, Li Y, Liu D, Huang Z. Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma. Head & Neck. 2024. doi:10.1002/hed.27865

BibTeX
@article{Min2024,
  author = {Min, Lei and Weng, Yujing and Li, Yuan and Liu, Die and Huang, Zhiheng},
  title = {Comparison of unilateral versus bilateral central neck dissection for clinically invasive papillary thyroid carcinoma},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27865}
}
Kostenlos starten →